Wells Fargo & Company MN Raises Position in U.S. Physical Therapy, Inc. (USPH)

Wells Fargo & Company MN increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 9.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 112,210 shares of the company’s stock after buying an additional 10,037 shares during the quarter. Wells Fargo & Company MN owned about 0.88% of U.S. Physical Therapy worth $13,307,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Acadian Asset Management LLC purchased a new position in U.S. Physical Therapy in the second quarter valued at about $106,000. Harvest Fund Management Co. Ltd purchased a new position in U.S. Physical Therapy in the third quarter valued at about $190,000. Cambridge Investment Research Advisors Inc. purchased a new position in U.S. Physical Therapy in the second quarter valued at about $219,000. Itau Unibanco Holding S.A. purchased a new position in U.S. Physical Therapy in the second quarter valued at about $235,000. Finally, PNC Financial Services Group Inc. raised its position in U.S. Physical Therapy by 62.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock valued at $256,000 after purchasing an additional 1,031 shares during the period. 99.58% of the stock is currently owned by institutional investors and hedge funds.

NYSE:USPH opened at $111.63 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.93 and a current ratio of 1.93. U.S. Physical Therapy, Inc. has a 12 month low of $70.10 and a 12 month high of $129.65. The stock has a market capitalization of $1.40 billion, a price-to-earnings ratio of 45.72, a P/E/G ratio of 3.86 and a beta of 1.21.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 1st. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The company had revenue of $113.10 million for the quarter, compared to analyst estimates of $112.79 million. U.S. Physical Therapy’s revenue for the quarter was up 9.8% compared to the same quarter last year. Equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.55 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 7th. Stockholders of record on Friday, November 9th were paid a dividend of $0.23 per share. The ex-dividend date of this dividend was Thursday, November 8th. This represents a $0.92 annualized dividend and a dividend yield of 0.82%. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.

Several research firms have commented on USPH. Cantor Fitzgerald raised their price objective on U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research report on Friday, November 2nd. TheStreet lowered U.S. Physical Therapy from a “b” rating to a “c+” rating in a research report on Friday, November 2nd. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $113.67.

In other news, CFO Lawrance W. Mcafee sold 3,100 shares of the firm’s stock in a transaction dated Friday, November 2nd. The stock was sold at an average price of $113.29, for a total transaction of $351,199.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Mark J. Brookner sold 2,500 shares of the firm’s stock in a transaction dated Friday, September 21st. The shares were sold at an average price of $116.00, for a total value of $290,000.00. The disclosure for this sale can be found here. Insiders have sold 8,100 shares of company stock valued at $927,949 over the last 90 days. Insiders own 2.50% of the company’s stock.

WARNING: “Wells Fargo & Company MN Raises Position in U.S. Physical Therapy, Inc. (USPH)” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/12/08/wells-fargo-company-mn-raises-position-in-u-s-physical-therapy-inc-usph.html.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: Systematic Risk and Investors

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply